Nationwide Fund Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q4 | – | Sell |
-24,500
| Closed | -$3.58M | – | 1051 |
|
2017
Q3 | $3.58M | Buy |
24,500
+3,500
| +17% | +$512K | 0.01% | 1171 |
|
2017
Q2 | $3.27M | Buy |
21,000
+9,750
| +87% | +$1.52M | 0.01% | 1215 |
|
2017
Q1 | $1.63M | Sell |
11,250
-11,250
| -50% | -$1.63M | 0.01% | 1500 |
|
2016
Q4 | $2.45M | Sell |
22,500
-65,720
| -74% | -$7.16M | 0.01% | 1320 |
|
2016
Q3 | $10.7M | Sell |
88,220
-58,810
| -40% | -$7.14M | 0.04% | 579 |
|
2016
Q2 | $20.8M | Buy |
147,030
+126,432
| +614% | +$17.9M | 0.09% | 261 |
|
2016
Q1 | $2.69M | Buy |
20,598
+4,266
| +26% | +$557K | 0.01% | 1213 |
|
2015
Q4 | $2.3M | Sell |
16,332
-8,126
| -33% | -$1.14M | 0.01% | 1304 |
|
2015
Q3 | $3.25M | Sell |
24,458
-24,481
| -50% | -$3.25M | 0.01% | 1131 |
|
2015
Q2 | $8.62M | Sell |
48,939
-31,960
| -40% | -$5.63M | 0.04% | 657 |
|
2015
Q1 | $14M | Buy |
80,899
+22,942
| +40% | +$3.96M | 0.06% | 437 |
|
2014
Q4 | $9.49M | Buy |
57,957
+2,557
| +5% | +$419K | 0.04% | 580 |
|
2014
Q3 | $8.9M | Buy |
55,400
+5,900
| +12% | +$947K | 0.04% | 621 |
|
2014
Q2 | $7.28M | Sell |
49,500
-33,416
| -40% | -$4.91M | 0.03% | 760 |
|
2014
Q1 | $11.5M | Buy |
82,916
+48,690
| +142% | +$6.75M | 0.05% | 442 |
|
2013
Q4 | $4.33M | Sell |
34,226
-16,310
| -32% | -$2.06M | 0.02% | 1030 |
|
2013
Q3 | $4.65M | Buy |
50,536
+10,920
| +28% | +$1M | 0.02% | 948 |
|
2013
Q2 | $2.72M | Buy |
+39,616
| New | +$2.72M | 0.01% | 1127 |
|